| Top 50 Most Viewed Posts This Month |
|---|
|
Today This Week Last Week This Month Last Month
|
| 1. Rosner: Short Interest Report As of Sat, Aug 3, '13 (7048) |
2. sherlock57: MGK2— You suggested the piece was gonna be (1817)  (25) |
| 3. Mr3Putt: Wowza new branding for CytoDyn! (1695) (17) |
| 4. Cycl2R: I don’t believe it has been noted here that the (1232) (12) |
| 5. MJS719: Thank you brentie for the reminder of how (1214) (10) |
| 6. Chasing Stars: Getting started on Investors Hangout. Are you (1175) (14) |
| 7. biloxiblues: We have a connection with the White House and (1043) (5) |
| 8. MGK_2: So, in the experiment, they took 4 monkeys (1021) (14) |
| 9. brentie: We get a mention. (1009) (14) |
| 10. My69z: Huge from WH on PBM middlemen: The Order builds (997) (11) |
| 11. sean007: According to sourced information over 2.2 million (961) (5) |
| 12. chazzledazzle: This is from 2016. Am I missing something new? (936) (1) |
| 13. ohm20: Regarding posting my scientific posts from here (930) (11) |
| 14. MGK_2: Very concise, so I figure it might get some (916) (13) |
| 15. MGK_2: ohm, as you know, most of us Greatly value your (875) (6) |
| 16. brentie: "Other changes from Makary include a shift away (855) (6) |
| 17. Ibam44: Hi all. I work in the film industry. I write (849) |
| 18. dfwl28: Excerpt: "Methods: By taking advantage of a newly (828) (11) |
| 19. sunray3: I agree. I posted this over on Reddit, It's what (827) (14) |
| 20. KenChowder: I may not be reading the abstract right. Yes, (821) (13) |
| 21. oMandarin: https://x.com/JimFergusonUK/status/19131254738752 (813) (13) |
| 22. sean007: In 2011, the FDA revoked Avastin's (Bevaziumab) (806) (5) |
| 23. testuser: A Agilent Technologies AA Alcoa Inc. AAN Aaron's (798) |
| 24. sean007: Cytodyn: Join the Team...careers @ cytodyn.com * (796) (4) |
| 25. ohm20: These would be the trial benchmarks LL would be (783) (23) |
| 26. Harpitdown: Good news, bad news. The "good" news is that as (782) (8) |
| 27. misiu143: I am very surprised Europe approved this drug at (778) (11) |
| 28. ohm20: would a Phase III that repeats the Phase II be (770) (13) |
| 29. sean007: Given what has been released publicly...any (758) (7) |
| 30. nelsonsjavaheads: This morning on CNBC, Scott Gottlieb said the (754) (17) |
| 31. sean007: Going back about five years ago, GSK (ViiV and (752) (7) |
| 32. Riztheinvestor: Something’s up. My spidey senses has been going (743) (8) |
| 33. Katangolo: Holy crap buddy! That’s an amazing find thanks (717) (3) |
| 34. My69z: Did LL cure Acinetobacter baumannii during (717) (7) |
| 35. TechGuru: SamaGong. In clinical trials ideally all the (704) (16) |
| 36. sean007: CCR5 has been in play for a very long time...it (703) (1) |
| 37. USS JOHNSTON: Regarding breast cancer, I see there are over 100 (699) (3) |
| 38. TechGuru: Not sure if this has been posted before, if so, (693) (9) |
| 39. Katangolo: Big stacks to small stacks if you don’t know (681) (3) |
| 40. KenChowder: Key Board Member Identity Revealed.... For those (681) (5) |
| 41. biloxiblues: This isn’t a rally cry. It’s a reality check. (672) (15) |
| 42. Katangolo: And surprise…BMGF are involved in funding new (669) (10) |
| 43. Cycl2R: “We’re removing Pharma members from the FDA (668) (3) |
| 44. TechGuru: Following some discussion earlier on about the (663) (17) |
| 45. Katangolo: Charting might be related to the realm of tea, (660) (6) |
| 46. My69z: Yep, DOD are always 1st to benefit too. Would be (659) (2) |
| 47. My69z: Testimonies 2021 & Prostate stage 4 Metastasis : (659) (5) |
| 48. Katangolo: Hear ya. And I hear that clock too. It’s (656) (4) |
| 49. sean007: Why is it... when I move money from my checking (655) (2) |
| 50. misiu143: Yes , just one thing... We the only drug without (651) (16) |
